Expression cloning of a reserpine-sensitive vesicular monoamine transporter
about
Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese populationVMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuseDistinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporterCloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoateA human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPsICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granulesVisualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesiclesVesicular monoamine transporters: structure-function, pharmacology, and medicinal chemistryHow addictive drugs disrupt presynaptic dopamine neurotransmissionRole of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficienciesVesicular monoamine transporter 2: role as a novel target for drug developmentModulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cellsPreferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cellsA biochemical and functional protein complex involving dopamine synthesis and transport into synaptic vesicles.Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumorsFunctional identification and molecular cloning of a human brain vesicle monoamine transporterActive transport of acetylcholine by the human vesicular acetylcholine transporterIdentification of a gastrin response element in the vesicular monoamine transporter type 2 promoter and requirement of 20 S proteasome subunits for transcriptional activityVesicular integrity in Parkinson's diseaseSerotonin circuits and anxiety: what can invertebrates teach us?Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate GPR52 for psychiatric disorders.VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicityRole of vesicular monoamine transporter type 2 in rodent insulin secretion and glucose metabolism revealed by its specific antagonist tetrabenazineThe vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nucleiCa2+-dependent activator proteins of secretion promote vesicular monoamine uptakeVesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cellsDifferentiation-associated Na+-dependent inorganic phosphate cotransporter (DNPI) is a vesicular glutamate transporter in endocrine glutamatergic systemsMonoamine transporter inhibitors and substrates as treatments for stimulant abuseA new VGLUT-specific potent inhibitor: pharmacophore of Brilliant YellowControl of histidine decarboxylase gene expression in enterochromaffin-like cellsDesign, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.The mechanism of histamine secretion from gastric enterochromaffin-like cells.Vmat2 heterozygous mutant mice display a depressive-like phenotype.The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivoExpression of neurotransmitter transporters for structural and biochemical studiesThe adrenal chromaffin granule: a model for large dense core vesicles of endocrine and nervous tissue.The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake.Molecular mechanisms of neurotransmitter release.Modification of the pH profile and tetrabenazine sensitivity of rat VMAT1 by replacement of aspartate 404 with glutamate.
P2860
Q21203891-C16BDF02-595E-4330-A414-6E77A7C0834CQ22242306-447BC938-526E-4928-864C-443A42596903Q24314400-C094CC3C-7BA9-469C-9BFD-05A7C433E2C9Q24319112-4AC4FB66-CB89-4000-B11F-49C0BC2DA905Q24321541-993F1F21-4D3A-4FAA-A334-92DFD14DDF61Q24563069-CD6A1C19-DDA0-4A58-AC9F-C8F75579C2CDQ24567830-79E8E748-FF3A-48E6-9E2F-30454827514AQ24601233-3F0DBC64-604F-44C9-B349-5F3363F7C245Q24631269-137573BF-5ED4-4E8F-9CB5-103B3DA9B1F3Q24633757-B10E3CDD-64CC-4AFC-9187-31F2AC2FBF95Q24647764-F4333DD9-09B3-4C36-9360-131E081497CDQ24651428-5C79E461-C9D7-4A62-8D4A-842C5314BA48Q24673073-C493E85B-69AB-4E18-AB38-1F398B7B9D1FQ27863413-09380D5B-7AE5-444E-8FD5-B2AB4267B419Q28188312-E45C862B-0CB3-4B24-BAD8-426D2B83D268Q28256704-E87E243C-F2CE-4F31-B646-9EE0C53B26D9Q28296121-B229D090-EE97-4684-B81C-76906C5F0505Q28298413-DBE77D7E-5204-465A-BE98-A87927D0925BQ28385737-96D06E1F-48E5-4FFD-ACFB-B6D30B672FF2Q28485318-602A5C85-83B3-47FC-BAAE-F64795D3BD45Q28506753-71280E35-00FC-4B3A-90F7-132635B4EB1CQ28512294-67235DFF-BC3F-4B62-A7D2-E2980E2D5939Q28565154-E03D20CF-21C5-4644-B30B-00BA46AB587EQ28568895-20E197D5-012F-4D07-A942-483109DDBE7DQ28570841-CCEF1A57-BBF2-47D3-B378-1CDA86BACCE1Q28579269-D34B3EB0-71C1-427C-9AB6-AEC8F1A67637Q28582682-31098760-238D-498D-8E4C-E38FA6C2949CQ30413718-46F38156-A2AD-473B-A625-64ADB0BF9AF1Q33630896-C45BFA4D-5874-4DC5-8E84-E90D87834B55Q33719549-2C8CFD32-FB71-4D48-A5F5-D425CC2E8176Q33738102-862ACCD3-EC85-4D40-A5F3-E6F01A2D0F71Q33774762-367AB810-6CAA-41C6-8CEB-4A7C30E12EA0Q33793549-3D2FF8FE-3053-4A71-9202-588E01CEA750Q33854736-6C82A3E5-BFAE-47C9-9F5C-D6F2829D5C16Q33919548-26C9A963-BC0D-429D-82A1-A2641694AB70Q34032615-244E48CD-5FEB-4535-9C78-01A5CAF2DDC3Q34087156-0BD419A2-8E08-4759-A36A-517A56889BD4Q34179669-9FD82D78-38E4-415F-B465-1ADFC416EA37Q34228641-B21B3C2E-2A14-4855-87F8-FBCA592FA546Q34384295-5FF70152-2835-4EA3-9709-BBBFEB718BD1
P2860
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
description
1992 nî lūn-bûn
@nan
1992 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@ast
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@en
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@nl
type
label
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@ast
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@en
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@nl
prefLabel
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@ast
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@en
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@nl
P2093
P2860
P356
P1476
Expression cloning of a reserpine-sensitive vesicular monoamine transporter
@en
P2093
B J Hoffman
J D Erickson
P2860
P304
P356
10.1073/PNAS.89.22.10993
P407
P577
1992-11-15T00:00:00Z